Neurosoft Software Production S.A.

Neurosoft Software Production S.A. is an Information and Communications Technology (ICT) firm specializing in the creation, enhancement, and ongoing support of comprehensive software solutions. Its expertise spans financial technology (Fintech), data analytics, systems architecture, and advanced cybersecurity operations, serving clients both within Greece and across the globe. Among its diverse product portfolio are Proxima+, a platform facilitating sales and supply chain financing; Angel, designed to safeguard maritime operations and onboard networks through monitoring, threat detection, and access control; and Illicium, a cutting-edge cyber deception solution. Further offerings include Neutrify, a comprehensive cybersecurity defense center that actively tracks, identifies, neutralizes, and investigates digital threats; RedyOps, a service focused on assessing organizational security posture and bolstering defenses against multifaceted attacks targeting personnel, technology, and physical infrastructure; and Enterprise Link, which delivers streamlined, secure cloud connectivity management through application-aware policies and network segmentation. Established in 1994, the company operates from its main office located in Athens, Greece.

Neurosoft Software Production S.A. trades as NRST.MI on MIL. The company is classified in Technology / Information Technology Services and reports in EUR.

The current profile places the business in Information Technology Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Neurosoft Software Production S.A. can be compared against peers such as Datrix S.p.A., ELES Semiconductor Equipment S.p.A., Eurotech S.p.A., Growens S.p.A., Maps S.p.A., Neosperience S.p.A..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of €17.27M, beta of 0.81, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NRST.MI currently shows total debt of N/A and beta of 0.81. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.neurosoft.gr

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.